Gabriel Cohn is Chief Medical Officer of Homology Medicines, Inc.. Currently has a direct ownership of 2,629 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Jan 05, 2022, when has been sold 1,661 shares (Common Stock) at a price of $3.78 per share, resulting in proceeds of $6,279. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.63K
0% 3M change
0% 12M change
Total Value Held $0

Gabriel Cohn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2022
SELL
Open market or private sale
$6,279 $3.78 p/Share
1,661 Reduced 38.72%
2,629 Common Stock
Jan 01 2022
BUY
Exercise of conversion of derivative security
-
4,290 Added 50.0%
4,290 Common Stock
GC

Gabriel Cohn

Chief Medical Officer
Bedford, MA

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Track Activities on FIXX